Free NAADAC Webinar
Recorded on Friday, December 18, 2020
A Recorded Webinar
The U.S. is now facing two intersecting health crises, the ongoing opioid overdose epidemic and the COVID-19 pandemic. Fortunately, we now live in a world where science can be quickly mobilized to find solutions to mitigate the worst effects. NIDA has swiftly responded to the COVID-19 crisis by supporting research in areas of basic science, prevention, treatment, epidemiology, and implementation, particularly at the intersection with substance use disorders. This presentation will provide an update on NIDA science underway to address the opioid crisis during the COVID pandemic and the implications for practice and policy.
- Participants will examine the impact of the COVID pandemic on preventing and treating substance use disorders.
- Participants will learn about research underway by NIDA to lessen the impact of these colliding public health problems.
- Participants will acquire an understanding of how science can inform policy and practice related to addressing substance use disorder.
Education is FREE to all professionals
Earn 2 Continuing Education Hours (CEs)
The CE certificate for this webinar will be available after the webinar takes place. NAADAC Members will be prompted to register for the CE quiz for free, while non-members will be prompted to pay a $25 processing fee to access the quiz. Upon passing the CE quiz, a CE Certificate will be immediately available to download in your profile. Click here for detailed step-by-step instructions for accessing your CE quiz and CE Certificate.
Click here for a complete list of organizations who approve NAADAC to provide continuing education hours.
This webinar is NOT eligible for ASWB ACE CE hours or NASW CE hours.
Jack B. Stein, MSW, PhD, joined NIDA in August 2012 as the Director of the Office of Science Policy and Communications (OSPC). He has over two decades of professional experience in leading national drug and HIV-related research, practice, and policy initiatives for NIDA, the Substance Abuse and Mental Health Services Administration (SAMHSA) and the Office of National Drug Control Policy (ONDCP) where, before coming back to NIDA, he served as the Chief of the Prevention Branch. In March 2019, Stein was appointed NIDA Chief of Staff.
Jessica Hulsey, BA
Founder of the Addiction Policy Forum
Philip Rutherford, BA
Chief Operating Officer at Faces & Voices of Recovery
Redonna Chandler, PhD
Director of the AIDS Research Program and the HEALing Communities Study at the National Institute on Drug Abuse (NIDA)
Kurt Rasmussen, PhD
Director of the Division of Therapeutics and Medical Consequences (DTMC) at the National Institute on Drug Abuse (NIDA)
Will M. Aklin, PhD
Director of the Behavioral Therapy Development Program at the National institute on Drug Abuse (NIDA)
Jennifer A. Hobin, PhD
Deputy Director and Legislative Advisor in the Office of Science Policy and Communications at the National Institute on Drug Abuse (NIDA)
Who Should Attend
Addiction professionals, employee assistance professionals, social workers, mental health counselors, professional counselors, psychologists, and other helping professionals that are interested in learning about addiction-related matters. Live closed captioning is available and the captioning capabilities are in compliance with the practices defined in Worldwide Web Consortium’s (W3C) Web Content Accessibility Guidelines (WCAG) and Section 508 of the Rehabilitation Act.
Questions or comments about NAADAC Education? Take a look at our Webinar FAQs or email NAADAC.
This presentation is for individual use only and may not be reproduced without permission from NAADAC.